celiprolol has been researched along with Disease Models, Animal in 6 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both celiprolol and candesartan showed cardioprotective effects in this heart failure model." | 7.73 | Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure. ( Hayashi, T; Kitaura, Y; Matsumura, Y; Mori, T; Ohkita, M; Okuda, N; Shimomura, H; Sohmiya, K; Yoshikawa, J; Yoshiyama, M, 2005) |
| "Both celiprolol and candesartan showed cardioprotective effects in this heart failure model." | 3.73 | Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure. ( Hayashi, T; Kitaura, Y; Matsumura, Y; Mori, T; Ohkita, M; Okuda, N; Shimomura, H; Sohmiya, K; Yoshikawa, J; Yoshiyama, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Gorosabel, MC | 1 |
| Dubacher, N | 1 |
| Meienberg, J | 1 |
| Matyas, G | 1 |
| Ishikura, F | 1 |
| Takano, Y | 1 |
| Ueyama, T | 1 |
| Mori, T | 1 |
| Hayashi, T | 1 |
| Sohmiya, K | 1 |
| Okuda, N | 1 |
| Shimomura, H | 1 |
| Ohkita, M | 1 |
| Matsumura, Y | 1 |
| Yoshiyama, M | 1 |
| Yoshikawa, J | 1 |
| Kitaura, Y | 1 |
| Chen, X | 1 |
| Minatoguchi, S | 1 |
| Arai, M | 1 |
| Wang, N | 1 |
| Lu, C | 1 |
| Narentuoya, B | 1 |
| Uno, Y | 1 |
| Misao, Y | 1 |
| Takemura, G | 1 |
| Fujiwara, T | 1 |
| Fujiwara, H | 1 |
| Motomura, S | 1 |
| Hashimoto, K | 1 |
6 other studies available for celiprolol and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Vascular Ehlers-Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic | 2020 |
Acute effects of beta-blocker with intrinsic sympathomimetic activity on stress-induced cardiac dysfunction in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Celiprolol; Disease Mo | 2012 |
Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Celiprolol; Disease Models, An | 2005 |
Celiprolol, a selective beta1-blocker, reduces the infarct size through production of nitric oxide in a rabbit model of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Celiprolol; Disease Models, Animal; Dose-Respo | 2007 |
Interactions of a new beta-blocker, celiprolol, with the calcium antagonists, diltiazem and nifedipine, on atrioventricular conduction.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Blood Pressure; Bundle of His; Calcium C | 1995 |